You are in:Home/Publications/Assessment of Subclinical Carotid Atherosclerosis in Patients with Chronic Obstructive Pulmonary Disease | |
Assist. samar samy ayoub abdelaal :: Publications: |
Title: | Assessment of Subclinical Carotid Atherosclerosis in Patients with Chronic Obstructive Pulmonary Disease |
Authors: | T.S.Essawy1, A.H.Al-Aarag1, I.M.Mustafa2, S.S.Ayoub1 and E.A.Mohamed1 |
Year: | 2021 |
Keywords: | chronic obstructive pulmonary disease, subclinical atherosclerosis, intima-media thickness, and carotid plaques. |
Journal: | Not Available |
Volume: | Not Available |
Issue: | Not Available |
Pages: | Not Available |
Publisher: | Not Available |
Local/International: | Local |
Paper Link: | Not Available |
Full paper | samar samy ayoub abdelaal_samar samy.pdf |
Supplementary materials | Not Available |
Abstract: |
Background: Elevated coronary morbidity and mortality of patients with chronic obstructive pulmonary diseases (COPD). Common intimate-media thickening (CCA-IMT) and carotid plaques are replacement markers of atherosclerosis and predictors of CV cases. Purpose and objectives: The present research aimed at assessing and evaluating the incidence of subclinical carotid atherosclerotic vascular diseases in patients with COPD Sujets and methods: a cross-sectional sample of 75 topics has been conducted; 25 stable COPD patients and 50 controls (25 patients with other chest diseases and 25 apparently healthy persons). They were divided into three groups: Group I: 25 healthy COPD patients (Global initiative for Chronic Obstructive Lung Disease Recommendations 2020 diagnosis and gravity of COPD) (GOLD 2020). Group II: 25 people and other underlying pulmonary conditions. Group III: 25 people seemingly well. The thesis lasted between 6 and 12 months Results: The prevalence of carotid disease in COPD patients was slightly higher than controls. Multinomial analyses of logistic regression have shown COPD to be an independent carotid plague indicator. Conclusion: Subclinical atherosclerosis is greatly correlated with COPD. These results will help to prepare appropriate strategies for CV prevention |